Skip to the page

Data / Form D filings / Nu-Med Plus, Inc.

Nu-Med Plus, Inc.: Form D filings

Nu-Med Plus, Inc., a biotechnology company in Salt Lake City, UT, filed 12 Form D notices with the SEC between 2012 and 2018. The latest, on December 7, 2018, reports $35,000 sold of a $600,000 offering to 2 investors.

Find out what Nu-Med Plus, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
455 EAST 500 SOUTH, SUITE #203, Salt Lake City, UT, 84111
Phone
(801) 746-3570
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Utah
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1543637

The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 7, 2018New notice$600,000$35,000$565,0002Oct 18, 2018sec.gov
Sep 20, 2017Amendment$700,000$660,405$39,5954Feb 1, 2017sec.gov
Sep 14, 2017New notice$400,000$45,000$355,0001Sep 8, 2017sec.gov
Feb 2, 2017New notice$700,000$300,000$400,0001Feb 1, 2017sec.gov
Aug 19, 2015New notice$30,000$2,500$27,5001Aug 13, 2015sec.gov
Apr 21, 2015New notice$30,000$30,000$01Apr 2, 2015sec.gov
Sep 2, 2014Amendment$171,500$164,000$7,5003Apr 18, 2014sec.gov
May 28, 2014Amendment$171,500$134,000$37,5002Apr 18, 2014sec.gov
May 1, 2014New notice$121,500$121,500$02Apr 18, 2014sec.gov
May 1, 2014Amendment$130,000$130,000$01Oct 28, 2013sec.gov
Oct 30, 2013New notice$130,000$50,000$80,0001Oct 28, 2013sec.gov
Mar 13, 2012New notice$125,000$87,653$37,34755Mar 1, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeffrey L. RobinsExecutive Officer, Director
Brett J. Earl, MDExecutive Officer, Director
William Grant MoonExecutive Officer, Director
Keith J. MerrellExecutive Officer
Craig W. MorrisonExecutive Officer, Director
Tom Grant TaitExecutive Officer, Director

Other biotechnology companies in Utah that filed recently

Every Form D from the week of Dec 3, 2018 · All recent filings in Utah · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Nu-Med Plus, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.